The MHC class I homolog of human cytomegalovirus is resistant to down-regulation mediated by the unique short region protein (US)2, US3, US6, and US11 gene products

被引:47
作者
Park, B
Oh, H
Lee, S
Song, YS
Shin, J
Sung, YC
Hwang, SY
Ahn, K
机构
[1] Korea Univ, Grad Sch Biotechnol, Sungbuk Gu, Seoul 136701, South Korea
[2] Catholic Univ Korea, Catholic Inst Med Sci, Seoul, South Korea
[3] Pohang Univ Sci & Technol, Div Mol & Life Sci, Pohang, South Korea
关键词
D O I
10.4049/jimmunol.168.7.3464
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Human CMV encodes four unique short region proteins (US), US2, US3, US6, and US 11, each independently sufficient for causing the down-regulation of MHC class I molecules on the cell surface. This down-regulation allows infected cells to evade recognition by cytotoxic T cells but leaves them susceptible to NK cells, which lyse cells that lack class I molecules. Another human CMV-encoded protein, unique long region protein 18 (UL18), is an MHC class I homolog that might provide a mechanism for inhibiting the NK cell response. The sequence similarities between MHC class I molecules and UL18 along with the ability of UL18 to form trimeric complexes with beta(2)-microglobulin and peptides led to the hypothesis that if the US and UL18 gene products coexist temporally during infection, the US proteins might down-regulate UL18 molecules, similar to their action on MHC class I molecules. We show here that temporal expression of US and UL18 genes partially overlaps during infection. However, unlike MHC class I molecules, the MHC class I homolog, UL18, is fully resistant to the down-regulation associated with the US2, US3, US6, and US11 gene products. The specific effect of US proteins on MHC class I molecules, but not on UL18, represents another example of how viral proteins have evolved to evade immune surveillance, avoiding fratricide by specifically targeting host proteins.
引用
收藏
页码:3464 / 3469
页数:6
相关论文
共 32 条
[1]   The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP [J].
Ahn, K ;
Gruhler, A ;
Galocha, B ;
Jones, TR ;
Wiertz, EJHJ ;
Ploegh, HL ;
Peterson, PA ;
Yang, Y ;
Fruh, K .
IMMUNITY, 1997, 6 (05) :613-621
[2]   Molecular mechanism and species specificity of TAP inhibition by herpes simplex virus protein ICP47 [J].
Ahn, K ;
Meyer, TH ;
Uebel, S ;
Sempe, P ;
Djaballah, H ;
Yang, Y ;
Peterson, PA ;
Fruh, K ;
Tampe, R .
EMBO JOURNAL, 1996, 15 (13) :3247-3255
[3]   Human cytomegalovirus inhibits antigen presentation by a sequential multistep process [J].
Ahn, KS ;
Angulo, A ;
Ghazal, P ;
Peterson, PA ;
Yang, Y ;
Fruh, K .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (20) :10990-10995
[4]   IMPAIRED INTRACELLULAR-TRANSPORT OF CLASS-I MHC ANTIGENS AS A POSSIBLE MEANS FOR ADENOVIRUSES TO EVADE IMMUNE SURVEILLANCE [J].
ANDERSSON, M ;
PAABO, S ;
NILSSON, T ;
PETERSON, PA .
CELL, 1985, 43 (01) :215-222
[5]   HUMAN CYTOMEGALO-VIRUS ENCODES A GLYCOPROTEIN HOMOLOGOUS TO MHC CLASS-I ANTIGENS [J].
BECK, S ;
BARRELL, BG .
NATURE, 1988, 331 (6153) :269-272
[6]   A COMPLEX BETWEEN THE MHC CLASS-I HOMOLOG ENCODED BY HUMAN CYTOMEGALOVIRUS AND BETA-2 MICROGLOBULIN [J].
BROWNE, H ;
SMITH, G ;
BECK, S ;
MINSON, T .
NATURE, 1990, 347 (6295) :770-772
[7]   The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18 [J].
Chapman, TL ;
Heikema, AP ;
Bjorkman, PJ .
IMMUNITY, 1999, 11 (05) :603-613
[8]   ANTIGEN PRESENTATION REQUIRES TRANSPORT OF MHC CLASS-1 MOLECULES FROM THE ENDOPLASMIC-RETICULUM [J].
COX, JH ;
YEWDELL, JW ;
EISENLOHR, LC ;
JOHNSON, PR ;
BENNINK, JR .
SCIENCE, 1990, 247 (4943) :715-718
[9]  
FAHNESTOCK ML, 1995, IMMUNITY, V3, P583, DOI 10.1016/1074-7613(95)90129-9
[10]   A VIRAL INHIBITOR OF PEPTIDE TRANSPORTERS FOR ANTIGEN PRESENTATION [J].
FRUH, K ;
AHN, K ;
DJABALLAH, H ;
SEMPE, P ;
VANENDERT, PM ;
TAMPE, R ;
PETERSON, PA ;
YANG, Y .
NATURE, 1995, 375 (6530) :415-418